ksoulstring

About Kenny Soulstring

Kenny Soulstring is an entrepreneurial visionary with a thirty year history developing and operating small to mid sized businesses. His experience in building a brand led to his interest in investing in small and emerging companies, and for the prior twenty years, his investments allow him to take part in new ventures without undertaking all of the legwork. Focused on finding compelling opportunities in the small cap sector, Soulstring enjoys the art of the build, watching a company develop from concept to maturity. His frequent contact with company management allows him to offer timely and relevant information, working to keep news fresh with a spicy commentary to match. Soulstring was raised in Miami Beach, Florida and plans to retire there when his hair turns fully gray.
With Antares Pharma's (ATRS) Xyosted DOA, Is Aytu BioScience (AYTU) The Beneficiary?
  • With Antares Pharma's (ATRS) Xyosted DOA, Is Aytu BioScience (AYTU) The Beneficiary?

With Antares Pharma’s (ATRS) Xyosted DOA, Is Aytu BioScience (AYTU) The Beneficiary?

By |October 17th, 2017|

For those who doubted the value and need for an alternative testosterone replacement therapy product, investors in Antares Pharma were stunned into certainty as they saw over $210 million in market cap evaporate in front of their eyes. The share price devastation came on the news that the FDA said, of Xyosted, that there […]

Ascent Solar (ASTI) Stock: CIGS Technology Will Make Them A Market Leader
  • Ascent Solar (ASTI) Stock: CIGS Technology Will Make Them A Market Leader

Ascent Solar (ASTI) Stock: CIGS Technology Will Make Them A Market Leader

By |October 10th, 2017|

The solar industry is the home to some of today’s most innovative and cutting-edge technology, and as time goes on, newer and more efficient advancements continue to revolutionize the market space. The evolution of the sector makes the solar industry a potentially lucrative field for investors to capitalize upon, and several unique opportunities are […]

Vitality Biopharma (VBIO) Stock: Targets Pediatric Crohn’s Disease Treatment With Cannabinoid Prodrug
  • Vitality Biopharma (VBIO) Stock: Targets Pediatric Crohn’s Disease Treatment With Cannabinoid Prodrug

Vitality Biopharma (VBIO) Stock: Targets Pediatric Crohn’s Disease Treatment With Cannabinoid Prodrug

By |October 3rd, 2017|

Vitality Biopharma is still one of the top three companies in the cannabis sector positioned to benefit tremendously from the continued passage of legislation legalizing marijuana-based compounds for medical use. Despite a share price that is showing a clear disconnect from competitors like GW Pharma (GWPH) and Arena Pharmaceuticals (ARNA), Vitality Biopharma (VBIO) continues […]

Ascent Solar (ASTI) Stock: Management Serves Up A Compelling Interview; Investors Need To Focus
  • Ascent Solar (ASTI) Stock: Management Serves Up A Compelling Interview; Investors Need To Focus

Ascent Solar (ASTI) Stock: Management Serves Up A Compelling Interview; Investors Need To Focus

By |September 28th, 2017|

Although some retail investors are feeling the burn from a tumultuous year in Ascent Solar stock, others believe that a buying opportunity is clearly at hand. Despite a history of convertible debenture financing and a sometimes fickle solar market, ASTI investors may finally be positioned to emerge as both near and long-term winners, with […]

OncoSec Medical Inc. (ONCS) Stock: Seeks Accelerated Approval To Treat Melanoma Indications
  • OncoSec Medical Inc. (ONCS) Stock: Seeks Accelerated Approval To Treat Melanoma Indications

OncoSec Medical Inc. (ONCS) Stock: Seeks Accelerated Approval To Treat Melanoma Indications

By |September 11th, 2017|

The fight against cancer has always been at the forefront of the biotech industry. As the methods of attacking and healing cancer can vary greatly between different companies, researchers are always searching for newer and more effective ways to combat the disease. Likewise, experienced biotech investors are always on the lookout for emerging opportunities […]

Choosing Wisely: Aytu BioScience (AYTUD) Stock vs. Lipocine, Inc. (LPCN) Stock
  • Choosing Wisely: Aytu BioScience (AYTUD) Stock vs. Lipocine, Inc. (LPCN) Stock

Choosing Wisely: Aytu BioScience (AYTUD) Stock vs. Lipocine, Inc. (LPCN) Stock

By |September 5th, 2017|

Both Aytu BioScience and Lipocine, Inc. are advancing novel testosterone replacement therapies, but when placed side by side, which stock may make investors pumped for joy?

As of today, the testosterone replacement therapy market is a hot sector, with companies focused on grabbing as much of the estimated $2 billion market as they can. Two […]

Why Aytu Bioscience’s (AYTUD) Fiera May Arouse The Female Sexual Dysfunction Market
  • Why Aytu Bioscience’s (AYTUD) Fiera May Arouse The Female Sexual Dysfunction Market

Why Aytu Bioscience’s (AYTUD) Fiera May Arouse The Female Sexual Dysfunction Market

By |August 30th, 2017|

For those paying attention, it’s evident that the Aytu Bioscience pipeline is going through a major growth spurt. And, while Aytu’s, Natesto, has been garnering a substantial portion of the sales and marketing focus, the company’s additional products, MiOXSYS and Fiera may prove to become just as valuable to future revenue streams. And, if […]

Aytu BioScience (AYTU) Stock: MiOXSYS Changing Infertility Technology
  • Aytu BioScience (AYTU) Stock: MiOXSYS Changing Infertility Technology

Aytu BioScience (AYTU) Stock: MiOXSYS Changing Infertility Technology

By |August 24th, 2017|

Aytu BioScience investors are counting on Natesto to lead the way toward profitability. And, while Natesto may indeed deliver AYTU to positive cash-flow status, or even net-profit levels within the next year, not recognizing the next strongest product in the lineup, MiOXSYS, would be like avoiding the obvious…not realizing that MiOXSYS is well deserving […]

Cancer Genetics (CGIX) Stock: vivoPharm Acquisition Broadens Precision Oncology Footprint
  • Cancer Genetics (CGIX) Stock: vivoPharm Acquisition Broadens Precision Oncology Footprint

Cancer Genetics (CGIX) Stock: vivoPharm Acquisition Broadens Precision Oncology Footprint

By |August 24th, 2017|

Cancer Genetics is a specialized company on the move, and while the current share price may lead investors to believe that CGIX is sitting idle and waiting for deals to come their way, nothing could be farther from the truth. Although the stock price sits at roughly $3.10 per share with a market cap […]

Green Spirit (GSRX) Stock: Can Spark An Economic Revival In Puerto Rico
  • Green Spirit (GSRX) Stock: Can Spark An Economic Revival In Puerto Rico

Green Spirit (GSRX) Stock: Can Spark An Economic Revival In Puerto Rico

By |August 24th, 2017|

Since Colorado and Washington’s legalization of recreational cannabis in 2012,1 investors seeking out the next lucrative opportunity have kept a close eye on the market. Although initially plagued with uncertainties concerning the viability of startup companies and the legal landscape, the cannabis industry has since matured to a degree that deserves the attention of any […]